Finanical Statements
Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda (RMDA.CA) Reports Its Financial Results (Standalone) for the Period From 01/01/2026 to 30/06/2026
Published at 16 August 2026 at 10:19Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-RamedaRelated stock:Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda stockAll Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda disclosures
Disclosure summary
Company Name: Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda
ISIN Code: EGS381B1C015
Currency: Egyptian Pound
F/S (Standalone) Period: From 01/01/2026 to 30/06/2026
Net profit: 208,350,627
F/S (Standalone) Period: From 01/01/2025 to 30/06/2025
Net Comparative profit: 169,227,592
Audit Status: Reviewed
Source: Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda
The Financial Statements in Arabic (816 KB)
The Financial Statements in English (1,014 KB)
ISIN Code: EGS381B1C015
Currency: Egyptian Pound
F/S (Standalone) Period: From 01/01/2026 to 30/06/2026
Net profit: 208,350,627
F/S (Standalone) Period: From 01/01/2025 to 30/06/2025
Net Comparative profit: 169,227,592
Audit Status: Reviewed
Source: Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda
The Financial Statements in Arabic (816 KB)
The Financial Statements in English (1,014 KB)